A cost-utility analysis of treatments for malignant liver tumours: a pilot project.

about

A cost-utility analysis of treatments for malignant liver tumours: a pilot project.

Item

http://www.wikidata.org/entity/Q36063431

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

A cost-utility analysis of treatments for malignant liver tumours: a pilot project.

@ast

A cost-utility analysis of treatments for malignant liver tumours: a pilot project.

@en

type

Item

label

A cost-utility analysis of treatments for malignant liver tumours: a pilot project.

@ast

A cost-utility analysis of treatments for malignant liver tumours: a pilot project.

@en

prefLabel

A cost-utility analysis of treatments for malignant liver tumours: a pilot project.

@ast

A cost-utility analysis of treatments for malignant liver tumours: a pilot project.

@en

P1476

A cost-utility analysis of treatments for malignant liver tumours: a pilot project.

@en

P2093

Andrew McKay

http://www.w3.org/2001/XMLSchema#string

Mark Taylor

http://www.w3.org/2001/XMLSchema#string

Trish Kutnikoff

http://www.w3.org/2001/XMLSchema#string

P2860

Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

Multi-attribute health status classification systems. Health Utilities Index.

Multi-attribute preference functions. Health Utilities Index.

Surgical treatment and other regional treatments for colorectal cancer liver metastases.

The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies.

Radiofrequency ablation of malignant liver tumors.

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.

Cost of allogeneic and autologous blood transfusion in Canada. Canadian Cost of Transfusion Study Group.

P304

42-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13651820600994541

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5519351

http://www.w3.org/2001/XMLSchema#string

P698

18333112

http://www.w3.org/2001/XMLSchema#string

P932

2020770

http://www.w3.org/2001/XMLSchema#string